Cascades Analytics is a bureau of neuropsychopharmacologist experts based in New York, US, and Paris, France.
We advise investors and funds through our in-depth and relevant analysis of emerging psychedelic and plastogen compounds from therapeutic start-ups in Series A. 
Our team has extensively collaborated with Nobel Laureate Paul Greengard and his team on various molecular architects involved in neuroplasticity (Lfc, Neurabin, spinophilin, DARPP-32, p11) and authored many scientific publications in Nature, Journal of Biological Chemistry, Journal of Neuroscience, and more. Resumes and publications are available upon request: alex@cascades-analytics.com